NYSE:RVTY Revvity Q3 2026 Earnings Date & Estimates $154.20 +2.04 (+1.34%) Closing price 10/9/2026 03:59 PM EasternExtended Trading$154.18 -0.02 (-0.01%) As of 10/9/2026 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Revvity is scheduled to report Q3 2026 earnings on Tuesday, November 3, 2026, before market opens. The conference call is scheduled for 7:30 AM ET. Research:ProfileEarnings HistoryForecast Upcoming Earnings Announcement QuarterQ3 2026Announcement DateNovember 3, 2026TimeBefore Market OpensConference Call7:30 AM ET Add to CalendarGoogle Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab) What Analysts Expect from Revvity in Q3 2026Revvity is expected to post earnings of $1.30 per share on revenue of $694.74 million. In the same quarter a year earlier Revvity reported $1.18 per share on revenue of $698.95 million. Revvity last reported on August 4, 2026, posting $1.41 per share and beating the $1.21 consensus estimate. Revvity has beaten the consensus EPS estimate in 8 of its last 8 quarters.Consensus EstimatesConsensus EPS$1.30Expected Revenue$694.74 millionPrior-Year EPS$1.18Prior-Year Revenue$698.95 millionExpected EPS Growth+10.2%Expected Revenue Growth-0.6%Recent Track RecordLast ReportedQ2 2026Last Quarter EPS$1.41 (Beat by +$0.20)Last Quarter Revenue$729.69 millionEPS Beat Rate8 of last 8 quartersPrepare for the Q3 2026 CallEarnings HistoryCompany ProfileQ2 2026 Earnings ReportQ1 2026 Earnings ReportQ4 2025 Earnings Report Revvity Q3 2026 Earnings FAQ When does Revvity report Q3 2026 earnings? Revvity (NYSE:RVTY) has confirmed it will report Q3 2026 earnings on Tuesday, November 3, 2026, before market opens. What time is Revvity's Q3 2026 earnings call? Revvity's Q3 2026 earnings conference call is scheduled for Tuesday, November 3, 2026 at 7:30 AM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date. What is the consensus EPS estimate for Revvity? Analysts expect Revvity to post earnings of $1.30 per share for Q3 2026. How much revenue is Revvity expected to report? The consensus revenue estimate for Revvity is $694.74 million for Q3 2026. Revvity Earnings HeadlinesRevvity earnings preview: What to expectOctober 7 at 9:48 AM | msn.comRevvity to Host Investor DayOctober 6, 2026 | marketscreener.comMA simple options setup that cuts through the noiseIan Cooper says most options traders overcomplicate the process, juggling countless indicators, strategies, and predictions. He argues a simpler approach can work just as well. His free report, The Simple Path To Success With Options, breaks down a repeatable trade setup, common rookie mistakes, and step-by-step blueprints designed to cut through market noise. No complex charts. No guesswork. Just a straightforward setup anyone can learn.October 10 at 1:00 AM | TradeWins (Ad)Revvity (NYSE:RVTY) CAO Anita Gonzales Sells 84 Shares of Company StockOctober 3, 2026 | americanbankingnews.comRevvity Goes Higher on Q3 FiguresOctober 2, 2026 | baystreet.caRevvity to Hold Earnings Call on November 3, 2026October 2, 2026 | marketscreener.comMSee More Revvity Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Revvity? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Revvity and other key companies, straight to your email. Email Address About RevvityRevvity (NYSE:RVTY), Inc. (NYSE:RVTY) is a life sciences and diagnostics company that provides technologies, products and services used in biological research, drug discovery, clinical testing and healthcare. The company serves pharmaceutical and biotechnology companies, academic and government research institutions, hospitals, clinical laboratories and other healthcare organizations. Its portfolio includes instruments, reagents, consumables, software and related services for areas such as genomics, proteomics, cellular analysis, imaging and multiplex testing. Revvity also supports reproductive health and newborn screening, infectious disease testing, and workflows used to identify and monitor diseases and evaluate potential therapies. Revvity was established in 2023 following the separation of PerkinElmer’s Applied, Food and Enterprise Services businesses from its life sciences and diagnostics operations. Based in Waltham, Massachusetts, the company serves customers internationally through a global commercial and support network. Prahlad Singh serves as president and chief executive officer.View Revvity ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles MarketBeat Week in Review – 10/05 - 10/09Delta Air Lines Faces a Fuel Crisis—But There's a Silver LiningPalantir’s Rally Puts Wall Street in Catch-Up Mode Ahead of November EarningsApplied Digital’s Hidden Moat Could Unlock Massive UpsideLevi's Stock Dip Reveals Value Opportunity Despite Q3 HeadwindsTilray Finds a Path to Growth Without Waiting on U.S. Cannabis ReformPepsiCo Stock Looks Poised to Bottom With High Yield, Deep Value Upcoming Earnings Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026)Wells Fargo & Company (10/13/2026)Johnson & Johnson (10/13/2026)UnitedHealth Group (10/13/2026)Bank of America (10/14/2026)BlackRock (10/14/2026)Morgan Stanley (10/14/2026)Progressive (10/14/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
